Peblimab
Pembrolizumab
- Concentración
- 100mg/ 4ml
- Fabricante
- Drug International Pharma
- Disponibilidad
- Disponible para obtener
Pembrolizumab 100mg/ 4ml — Injection, 1's Vial
¿Necesita ayuda?
Nuestro equipo de soporte multilingüe puede ayudarle con disponibilidad, envío y pedidos.
Chatear por WhatsApp
Escanear para WeChat
Sobre este medicamento
Originator: Keytruda by Merck Sharp & Dohme Corp., · Manufacturer: Drug International Pharma. Indication & Dosage: Peblimab (Pembrolizumab), generic Keytruda is a prescription medicine used to treat skin cancer (called melanoma, merkel cell carcinoma, cutaneous squamous cell carcinoma), non–small cell lung cancer (NSCLC), head and neck squamous cell cancer (HNSCC), classical Hodgkin lymphoma & primary mediastinal B-cell lymphoma (a type of non-Hodgkin's lymphoma), bladder cancer, MSI-H cancer, colorectal cancer, gastric cancer, esophageal cancer, cervical cancer (a type of cancer that occurs in a woman's cervix), liver cancer, kidney cancer, triple-negative breast cancer. Peblimab manufactured by 耀品国际有限公司 Ltd. in Bangladesh. Pembrolizumab has to inject slowly into a vein over 30 minutes once every 3 weeks or once every 6 weeks. Side Effects: The most common adverse reactions of Pembrolizumab are: Tiredness , swelling ankles/ feet/ hands, itchy skin, nausea , vomiting , abdominal pain, decreased appetite, diarrhea , rash , fever, cough , shortness of breath, constipation or trouble sleeping. The above information comes from the Internet. Please consult with doctor for medical advice.
Indicaciones
Esta información es solo de referencia y no constituye consejo médico. Consulte siempre a un profesional de la salud calificado.
